In silico discovery of beta-secretase inhibitors

TitleIn silico discovery of beta-secretase inhibitors
Publication TypeJournal Article
Year of Publication2006
AuthorsHuang D., Lüthi U., Kolb P., Cecchini M., Barberis A., Caflisch A.
JournalJournal of the American Chemical Society
Volume128
Issue16
Pagination5436-5443
Date Published2006 Apr 26
Type of ArticleResearch Article
ISSN0002-7863
KeywordsAmyloid Precursor Protein Secretases, Electrochemistry, Models, Molecular, Protease Inhibitors
Abstract

Alzheimer's disease, the most common amyloid-associated disorder, accounts for the majority of the dementia diagnosed after the age of 60. The cleavage of the β-amyloid precursor protein is initiated by β-secretase (BACE-1), a membrane-bound aspartic protease, which has emerged as an important but difficult protein target. Here, an in silico screening approach consisting of fragment-based docking, ligand conformational search by a genetic algorithm, and evaluation of free energy of binding was used to identify low-molecular-weight inhibitors of BACE-1. More than 300,000 small molecules were docked and about 15,000 prioritized according to a linear interaction energy model with evaluation of solvation by continuum electrostatics. Eighty-eight compounds were tested in vitro, and 10 of them showed an IC50 value lower than 100 μM in a BACE-1 enzymatic assay. Interestingly, the 10 active compounds shared a triazine scaffold. Moreover, four of them were active in an assay with mammalian cells (EC50 < 20 μM), indicating that they are cell-permeable. Therefore, these triazine derivatives are very promising lead candidates for BACE-1 inhibition. The discoveries of this series and two other series of nonpeptidic BACE-1 inhibitors demonstrate the usefulness of our in silico high-throughput screening approach.

DOI10.1021/ja0573108
pubindex

0077

Alternate JournalJ. Am. Chem. Soc.
PubMed ID16620115
Full Text PDF: 
SI PDF: